Overview of Dr. Muranski
Dr. Pawel Muranski is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Medical University of Warsaw and has been in practice 22 years. He is one of 25 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 64 doctors at New York-Presbyterian Hospital who specialize in Hematology. He has more than 70 publications and over 500 citings.
Office
161 Fort Washington Ave
New York, NY 10032
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology, 2003 - 2006
Medical University of WarsawClass of 1996
Certifications & Licensure
NY State Medical License 2017 - 2025
IL State Medical License 1999 - 2020- American Board of Internal Medicine Hematology
Clinical Trials
- Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections Start of enrollment: 2014 Sep 03
- R-MVST Cells for Treatment of Viral Infections Start of enrollment: 2022 May 03
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 27 citationsBK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study.Irene Cortese, Erin S Beck, Omar Al-Louzi, Joan Ohayon, Frances Andrada
The Lancet. Neurology. 2021-08-01 - 633 citationsTumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsSergio A. Quezada, Tyler R. Simpson, Karl S. Peggs, Taha Merghoub, Jelena Vider
The Journal of Experimental Medicine. 2010-03-15 - 305 citationsAdoptively transferred effector cells derived from naïve rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S. Hinrichs, Zachary A. Borman, Lydie Cassard, Luca Gattinoni, Rosanne Spolski
Proceedings of the National Academy of Sciences of the United States of America. 2009-10-13
Press Mentions
“Living Drug” Created by Columbia Immunologists May Save Transplanted OrgansDecember 9th, 2022- Are Immunocompromised Patients Left Out by COVID Vaccines?July 26th, 2021
- Shop TalkNovember 10th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
